View : 589 Download: 0
Reduced immunoreactivities of B-type natriuretic peptide in pulmonary arterial hypertension rats after ranolazine treatmen
- Title
- Reduced immunoreactivities of B-type natriuretic peptide in pulmonary arterial hypertension rats after ranolazine treatmen
- Authors
- Lee J.C.; Kim K.C.; Choe S.Y.; Hong Y.M.
- Ewha Authors
- 홍영미; 김관창
- SCOPUS Author ID
- 홍영미; 김관창
- Issue Date
- 2016
- Journal Title
- Anatomy and Cell Biology
- ISSN
- 2093-3665
- Citation
- Anatomy and Cell Biology vol. 49, no. 1, pp. 7 - 14
- Keywords
- B-type natriuretic peptide; Heart; Pulmonary artery hypertension; Ranolazine; Right ventricles
- Publisher
- Korean Association of Anatomists
- Indexed
- SCOPUS; KCI
- Document Type
- Article
- Abstract
- Pulmonary arterial hypertension (PAH) is a severe pulmonary vascular disease characterized by sustained increase in the pulmonary arterial pressure and excessive thickening and remodeling of the distal small pulmonary arteries. During disease progression, structural remodeling of the right ventricular (RV) impairs pump function, creates pro-arrhythmic substrates and triggers for arrhythmias. Notably, RV failure and lethal arrhythmias are major contributors to cardiac death in PAH that are not directly addressed by currently available therapies. Ranolazine (RAN) is an anti-anginal, anti-ischemic drug that has cardioprotective effects of heart dysfunction. RAN also has anti-arrhythmic effects due to inhibition of the late sodium current in cardiomyocytes. Therefore, we hypothesized that RAN could reduce the mal-adaptive structural remodeling of the RV, and prevent triggered ventricular arrhythmias in the monocrotaline-induced rat model of PAH. RAN reduced ventricular hypertrophy, reduced levels of B-type natriuretic peptide, and decreased the expression of fibrosis. In addition, RAN prevented cardiovascular death in rat model of PAH. These results support the notion that RAN can improve the functional properties of the RV, highlighting its potential benefits in the setting of heart impairment. © 2016. Anatomy & Cell Biology.
- DOI
- 10.5115/acb.2016.49.1.7
- Appears in Collections:
- 의과대학 > 의학과 > Journal papers
- Files in This Item:
There are no files associated with this item.
- Export
- RIS (EndNote)
- XLS (Excel)
- XML